RVPH
NASDAQ · Pharmaceuticals
Reviva Pharmaceuticals Holdi
$0.48
-0.02 (-4.40%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,477.1% upside
Low Target
$10.29
Average Target
$12.37
High Target
$18.62
Current Price
$0.48
Current
$0.48
$0.48
Target
$12.37
$12.37
$10.29
$12.37 avg
$18.62
Scenario Analysis
Bear Case
$10.29
2,043.8%
Low target
Base Case
$12.37
+2,477.1%
Avg target
Bull Case
$18.62
+3,779.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$17.20
-97.2% from high
52-Week Low
$0.26
+83.2% from low
Target vs 52W High
$12.37
-28.1% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +14.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.2% |
| MRK | Buy | 36 | 72% | $159.27 | +6.5% |
| PFE | Hold | 36 | 39% | $33.90 | +22.2% |
| BMY | Hold | 35 | 43% | $174.50 | +178.7% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +194.2% |